Tycoon Group updates on continuing connected transactions

Tycoon Group Holdings Limited has released additional information concerning its connected transactions related to distribution agreements with Europharm Hong Kong and Jacobson Medical. The company entered into supplemental agreements on May 29, 2025, to extend the fixed period for each Relevant Distribution Agreement, concluding on March 31, 2028. The proposed annual cap for Europharm Products under the Europharm Hong Kong Distribution Agreement for 3M2028 is HK$800,000, while the cap for Jacobson Medical Products under the Jacobson Medical Distribution Agreement is HK$1,600,000 for the same period. These transactions, while subject to annual review and disclosure, are exempt from circular and shareholder approval requirements due to their percentage ratio falling between 0.1% and 5% under Listing Rules. The update does not affect other previously announced information.